Gefitinib Combined With Thalidomide to Treat NSCLC
Clinical trial NCT02387086 · UNKNOWN
Trial details
- NCT number
- NCT02387086
- Sponsor
- Bai Jun
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2017-05-01
- Enrollment
- 380
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.